However, several factors—including age, serum PSA, recurrence risk, prognostic grouping, lymph node metastasis, CD8 and PD-1 levels, and combined IL-38 with CD8 or PD-1—are not significantly associated with survival outcomes (18). The gene discussed is CD8A; the disease is metastatic malignant neoplasm in the lymph nodes.